Skip to main content

Table 3 68Ga-PSMA-11 PET findings

From: PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

Characteristic Patients
miTNM classification, no. (%), n = 186
 miT status
  2u 73 (39.2%)
  2m 52 (28%)
  3a 27 (14.5%)
  3b 24 (12.9%)
  4 10 (5.4%)
 miN status
  0 168 (90.3%)
  1 7 (3.8%)
  2 11 (5.9%)
 miM status
  0 179 (96.2%)
  1a 3 (1.6%)
  1b 4 (2.2%)
PSMA-PET findings of prostatic lesions, median (IQR), n = 183a
 SUVmax 10.6 (6.4–18.9)
 SUVmean 6.2 (3.2–11.0)
 TV 3.9 (1.7–10.5)
 TL 24.7 (15.9–44.4)
  1. IQR interquartile range, PET positron emission tomography, PSMA prostate-specific membrane antigen, SUV standardized uptake value, TL total lesion, TV tumor volume
  2. aThree patients had PSMA negative prostate cancer. miTNM of these patients were classified based on MRI images